Walk into almost any dinner party or gathering and mention Ozempic or other GLP-1s. The reaction is nearly always the same: People lower their voices. They hesitate. They start qualifying what they ...
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...
4don MSN
Study finds that people who took GLP-1 drugs regain about 10 kg within 18 months of stopping
Research shows that individuals using GLP-1 medications for weight loss, such as Ozempic, regain nearly 22 pounds within 18 months of stopping.
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...
Share on Pinterest New research suggests that GLP-1s could offer dual benefits for treating both metabolic and mental health issues. Catherine Falls Commercial/Getty Images A new study found that ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had greater improvements in total cholesterol and systolic BP with once-weekly ...
Canada's largest Canadian‑based global health company, today announced that Health Canada has approved Apo‑Semaglutide ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. GLP-1 medications like semaglutide (Ozempic) have a number of ...
Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years — ...
By Rishika Sadam March 31 (Reuters) - Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results